Why the Cochrane risk of bias tool should include funding source as a standard item
- PMID: 24575439
- PMCID: PMC10898502
- DOI: 10.1002/14651858.ED000075
Why the Cochrane risk of bias tool should include funding source as a standard item
References
-
- Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org
-
- Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012;12:MR000033. doi.org/10.1002/14651858.MR000033.pub2 - PubMed
-
- Hart B, Lundh A, Bero L. Effect of reporting bias on meta‐analyses of drug trials: reanalysis of meta‐analyses. BMJ 2012;343:d7202. doi.org/10.1136/bmj.d7202 - PubMed
-
- Als‐Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003;290(7):921–8. doi.org/10.1001/jama.290.7.921 - PubMed
-
- Odierna DH, Forsyth SR, White J, Bero LA. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Accountability in Research 2013;20(2):127–141. doi.org/10.1080/08989621.2013.768931 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources